Michael Casasanta

Dr. Michael Casasanta is an Associate at Outcome Capital. He trained as a research scientist with broad exposure to cutting-edge infectious disease, and oncology-based technologies.

Dr. Casasanta is a published author with numerous peer-reviewed manuscripts in addition to his significant contributions in several multi-million-dollar NIH-funded grants supporting his research. During his time in research, Dr. Casasanta developed a passion to enrich the personal and professional lives of his colleagues. He served in the Graduate Student Assembly of Virginia Tech and the Student Council of the Microscopy Society of America to provide community building and professional development events for both students and early career professionals. Subsequent to his academic studies, Michael served as a Venture Fellow at Nodes Advisors AG, a European-based corporate advisory firm. There, Dr. Casasanta led due diligence processes evaluating the scientific and economic potential of emerging biotechnology companies while assisting in the preparation of transactional materials for the Fund’s portfolio companies.

Dr. Casasanta received dual B.S degrees in Biology and Biochemistry and earned his Ph.D. in Biochemistry from Virginia Tech’s flagship campus in Blacksburg, VA. He is a FINRA Registered Securities Representative holding Series 7, 79 and 63 registrations.